SlideShare a Scribd company logo

Quality Use of Medicines

•
•
K
kbaskett
Economy & FinanceHealth & Medicine
1 of 15
Quality Use of Medicines A brief summary
What do we mean by “medicine” ,[object Object],[object Object],[object Object],[object Object]
What is Quality Use of Medicines? ,[object Object],[object Object],[object Object],[object Object],[object Object]
QUM cont’d ,[object Object],[object Object],[object Object],[object Object]
QUM cont’d ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
QUM cont’d ,[object Object],[object Object],[object Object],[object Object],[object Object]
National Medicines Policy 2000 ,[object Object]
How does the National Medicines Policy work? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Central Objectives ACCESS Timely access to medicines, at a cost the individual and community can afford QUALITY PRODUCTS Medicines meet Appropriate standards of quality, safety and efficacy QUALITY USE OF MEDICINES Judicious, appropriate, safe and effective use of medicines INDUSTRY Maintenance of a responsible and viable medicines industry
Objectives of the National Strategy for QUM ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
QUM is ,[object Object],[object Object],[object Object],[object Object]
Key Partners ,[object Object],[object Object],[object Object],[object Object]
Key Partners cont’d ,[object Object],[object Object],[object Object]
Key Partners cont’d ,[object Object],[object Object]
“ Think Global, Act Local” ,[object Object],[object Object]

Recommended

Quality use medicine
Quality use medicineQuality use medicine
Quality use medicineFARAZULHODA
 
BUILDING BLOCKS & evaluation process in qum.pptx
BUILDING BLOCKS & evaluation process in qum.pptxBUILDING BLOCKS & evaluation process in qum.pptx
BUILDING BLOCKS & evaluation process in qum.pptxAmeena Kadar
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
PharmacoeconomicsDr VARUN RAGHAVAN
 
COMMUNICATION IN QUM.pptx
COMMUNICATION IN QUM.pptxCOMMUNICATION IN QUM.pptx
COMMUNICATION IN QUM.pptxAmeena Kadar
 
Measurement of outcome v5
Measurement of outcome v5Measurement of outcome v5
Measurement of outcome v5aiswarya thomas
 
Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology ABUBAKRANSARI2
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
PharmacoeconomicsAsma Ashraf
 
Pharmacoeconomics 22 feb 2018
Pharmacoeconomics 22 feb 2018Pharmacoeconomics 22 feb 2018
Pharmacoeconomics 22 feb 2018Dr Roohana Hasan
 

Recommended

Quality use medicine
Quality use medicineQuality use medicine
Quality use medicineFARAZULHODA
 
BUILDING BLOCKS & evaluation process in qum.pptx
BUILDING BLOCKS & evaluation process in qum.pptxBUILDING BLOCKS & evaluation process in qum.pptx
BUILDING BLOCKS & evaluation process in qum.pptxAmeena Kadar
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
PharmacoeconomicsDr VARUN RAGHAVAN
 
COMMUNICATION IN QUM.pptx
COMMUNICATION IN QUM.pptxCOMMUNICATION IN QUM.pptx
COMMUNICATION IN QUM.pptxAmeena Kadar
 
Measurement of outcome v5
Measurement of outcome v5Measurement of outcome v5
Measurement of outcome v5aiswarya thomas
 
Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology ABUBAKRANSARI2
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
PharmacoeconomicsAsma Ashraf
 
Pharmacoeconomics 22 feb 2018
Pharmacoeconomics 22 feb 2018Pharmacoeconomics 22 feb 2018
Pharmacoeconomics 22 feb 2018Dr Roohana Hasan
 
ROLE OF COMMUNITY PHARMACIST IN MALARIAL CONTROL PROGRAM
ROLE OF COMMUNITY PHARMACIST IN MALARIAL CONTROL PROGRAMROLE OF COMMUNITY PHARMACIST IN MALARIAL CONTROL PROGRAM
ROLE OF COMMUNITY PHARMACIST IN MALARIAL CONTROL PROGRAMMALINIR14
 
ROLE OF INDUSTRY IN QUM IN MEDICINE DEVELOPMENT 1.pptx
ROLE OF INDUSTRY IN QUM IN MEDICINE DEVELOPMENT 1.pptxROLE OF INDUSTRY IN QUM IN MEDICINE DEVELOPMENT 1.pptx
ROLE OF INDUSTRY IN QUM IN MEDICINE DEVELOPMENT 1.pptxAmeena Kadar
 
ADR MONITORING IN COMMUNITY PHARMACY ^0 RESEARCH.pptx
ADR MONITORING IN COMMUNITY PHARMACY ^0 RESEARCH.pptxADR MONITORING IN COMMUNITY PHARMACY ^0 RESEARCH.pptx
ADR MONITORING IN COMMUNITY PHARMACY ^0 RESEARCH.pptxShivaji University
 
PHARMACOEPIDEMIOLOGY
PHARMACOEPIDEMIOLOGYPHARMACOEPIDEMIOLOGY
PHARMACOEPIDEMIOLOGYAISHASID
 
Pharmacoeconomics
Pharmacoeconomics Pharmacoeconomics
Pharmacoeconomics academic
 
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptxINTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptxAmeena Kadar
 
Unit 1 pharmacoepidemiology
Unit 1 pharmacoepidemiologyUnit 1 pharmacoepidemiology
Unit 1 pharmacoepidemiologyDr. Supriya Suman
 
DRUG UTILIZATION EVALUATION
DRUG UTILIZATION EVALUATIONDRUG UTILIZATION EVALUATION
DRUG UTILIZATION EVALUATIONaishuanju
 
Pharmacoeconomics ppt.
Pharmacoeconomics ppt.Pharmacoeconomics ppt.
Pharmacoeconomics ppt.shahvijita
 
Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens pavithra vinayak
 
DRUG USE MEASURES.pptx
DRUG USE MEASURES.pptxDRUG USE MEASURES.pptx
DRUG USE MEASURES.pptxAmeena Kadar
 
Drug Utilization review
Drug Utilization review Drug Utilization review
Drug Utilization review Pooja Panjwani
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
PharmacoeconomicsSanghmitra Priyadarshini
 
introduction to Pharmacoepidemiology
introduction to Pharmacoepidemiology introduction to Pharmacoepidemiology
introduction to Pharmacoepidemiology aiswarya thomas
 
Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)
Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)
Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)Anjali Rarichan
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
PharmacoeconomicsSanthi Dasari
 
14ab1 t0004 therapeutic guidelines
14ab1 t0004 therapeutic guidelines14ab1 t0004 therapeutic guidelines
14ab1 t0004 therapeutic guidelinesRamesh Ganpisetti
 
Pharmacoepideiology
PharmacoepideiologyPharmacoepideiology
PharmacoepideiologyUSmile Ï Ṩṃïlệ
 
Drug Therapy Monitiring
Drug Therapy MonitiringDrug Therapy Monitiring
Drug Therapy Monitiringmaneeshkumar reddy
 
Developing therapeutic guidelines
Developing therapeutic guidelines Developing therapeutic guidelines
Developing therapeutic guidelines Irene Vadakkan
 
How to Reduce Readmissions by Changing Patient Education
How to Reduce Readmissions by Changing Patient EducationHow to Reduce Readmissions by Changing Patient Education
How to Reduce Readmissions by Changing Patient EducationChuck Jones
 
8. Acute Lymphoblastic Leukemia
8. Acute Lymphoblastic Leukemia8. Acute Lymphoblastic Leukemia
8. Acute Lymphoblastic LeukemiaWhiteraven68
 

More Related Content

What's hot

ROLE OF COMMUNITY PHARMACIST IN MALARIAL CONTROL PROGRAM
ROLE OF COMMUNITY PHARMACIST IN MALARIAL CONTROL PROGRAMROLE OF COMMUNITY PHARMACIST IN MALARIAL CONTROL PROGRAM
ROLE OF COMMUNITY PHARMACIST IN MALARIAL CONTROL PROGRAMMALINIR14
 
ROLE OF INDUSTRY IN QUM IN MEDICINE DEVELOPMENT 1.pptx
ROLE OF INDUSTRY IN QUM IN MEDICINE DEVELOPMENT 1.pptxROLE OF INDUSTRY IN QUM IN MEDICINE DEVELOPMENT 1.pptx
ROLE OF INDUSTRY IN QUM IN MEDICINE DEVELOPMENT 1.pptxAmeena Kadar
 
ADR MONITORING IN COMMUNITY PHARMACY ^0 RESEARCH.pptx
ADR MONITORING IN COMMUNITY PHARMACY ^0 RESEARCH.pptxADR MONITORING IN COMMUNITY PHARMACY ^0 RESEARCH.pptx
ADR MONITORING IN COMMUNITY PHARMACY ^0 RESEARCH.pptxShivaji University
 
PHARMACOEPIDEMIOLOGY
PHARMACOEPIDEMIOLOGYPHARMACOEPIDEMIOLOGY
PHARMACOEPIDEMIOLOGYAISHASID
 
Pharmacoeconomics
Pharmacoeconomics Pharmacoeconomics
Pharmacoeconomics academic
 
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptxINTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptxAmeena Kadar
 
DRUG UTILIZATION EVALUATION
DRUG UTILIZATION EVALUATIONDRUG UTILIZATION EVALUATION
DRUG UTILIZATION EVALUATIONaishuanju
 
Pharmacoeconomics ppt.
Pharmacoeconomics ppt.Pharmacoeconomics ppt.
Pharmacoeconomics ppt.shahvijita
 
Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens pavithra vinayak
 
DRUG USE MEASURES.pptx
DRUG USE MEASURES.pptxDRUG USE MEASURES.pptx
DRUG USE MEASURES.pptxAmeena Kadar
 
Drug Utilization review
Drug Utilization review Drug Utilization review
Drug Utilization review Pooja Panjwani
 
introduction to Pharmacoepidemiology
introduction to Pharmacoepidemiology introduction to Pharmacoepidemiology
introduction to Pharmacoepidemiology aiswarya thomas
 
Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)
Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)
Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)Anjali Rarichan
 
14ab1 t0004 therapeutic guidelines
14ab1 t0004 therapeutic guidelines14ab1 t0004 therapeutic guidelines
14ab1 t0004 therapeutic guidelinesRamesh Ganpisetti
 
Developing therapeutic guidelines
Developing therapeutic guidelines Developing therapeutic guidelines
Developing therapeutic guidelines Irene Vadakkan
 

What's hot (20)

ROLE OF COMMUNITY PHARMACIST IN MALARIAL CONTROL PROGRAM
ROLE OF COMMUNITY PHARMACIST IN MALARIAL CONTROL PROGRAMROLE OF COMMUNITY PHARMACIST IN MALARIAL CONTROL PROGRAM
ROLE OF COMMUNITY PHARMACIST IN MALARIAL CONTROL PROGRAM
 
ROLE OF INDUSTRY IN QUM IN MEDICINE DEVELOPMENT 1.pptx
ROLE OF INDUSTRY IN QUM IN MEDICINE DEVELOPMENT 1.pptxROLE OF INDUSTRY IN QUM IN MEDICINE DEVELOPMENT 1.pptx
ROLE OF INDUSTRY IN QUM IN MEDICINE DEVELOPMENT 1.pptx
 
ADR MONITORING IN COMMUNITY PHARMACY ^0 RESEARCH.pptx
ADR MONITORING IN COMMUNITY PHARMACY ^0 RESEARCH.pptxADR MONITORING IN COMMUNITY PHARMACY ^0 RESEARCH.pptx
ADR MONITORING IN COMMUNITY PHARMACY ^0 RESEARCH.pptx
 
PHARMACOEPIDEMIOLOGY
PHARMACOEPIDEMIOLOGYPHARMACOEPIDEMIOLOGY
PHARMACOEPIDEMIOLOGY
 
Pharmacoeconomics
Pharmacoeconomics Pharmacoeconomics
Pharmacoeconomics
 
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptxINTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
 
Unit 1 pharmacoepidemiology
Unit 1 pharmacoepidemiologyUnit 1 pharmacoepidemiology
Unit 1 pharmacoepidemiology
 
DRUG UTILIZATION EVALUATION
DRUG UTILIZATION EVALUATIONDRUG UTILIZATION EVALUATION
DRUG UTILIZATION EVALUATION
 
Pharmacoeconomics ppt.
Pharmacoeconomics ppt.Pharmacoeconomics ppt.
Pharmacoeconomics ppt.
 
Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens
 
DRUG USE MEASURES.pptx
DRUG USE MEASURES.pptxDRUG USE MEASURES.pptx
DRUG USE MEASURES.pptx
 
Drug Utilization review
Drug Utilization review Drug Utilization review
Drug Utilization review
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
introduction to Pharmacoepidemiology
introduction to Pharmacoepidemiology introduction to Pharmacoepidemiology
introduction to Pharmacoepidemiology
 
Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)
Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)
Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
14ab1 t0004 therapeutic guidelines
14ab1 t0004 therapeutic guidelines14ab1 t0004 therapeutic guidelines
14ab1 t0004 therapeutic guidelines
 
Pharmacoepideiology
PharmacoepideiologyPharmacoepideiology
Pharmacoepideiology
 
Drug Therapy Monitiring
Drug Therapy MonitiringDrug Therapy Monitiring
Drug Therapy Monitiring
 
Developing therapeutic guidelines
Developing therapeutic guidelines Developing therapeutic guidelines
Developing therapeutic guidelines
 

Viewers also liked

How to Reduce Readmissions by Changing Patient Education
How to Reduce Readmissions by Changing Patient EducationHow to Reduce Readmissions by Changing Patient Education
How to Reduce Readmissions by Changing Patient EducationChuck Jones
 
8. Acute Lymphoblastic Leukemia
8. Acute Lymphoblastic Leukemia8. Acute Lymphoblastic Leukemia
8. Acute Lymphoblastic LeukemiaWhiteraven68
 
Medicines optimisation, pop up uni, 9am, 3 september 2015
Medicines optimisation, pop up uni, 9am, 3 september 2015Medicines optimisation, pop up uni, 9am, 3 september 2015
Medicines optimisation, pop up uni, 9am, 3 september 2015NHS England
 
Providing quality pediatric pain management during end of life care
Providing quality pediatric pain management during end of life careProviding quality pediatric pain management during end of life care
Providing quality pediatric pain management during end of life carecassidydanielle
 
Enabling Translational Medicine with e-Science
Enabling Translational Medicine with e-ScienceEnabling Translational Medicine with e-Science
Enabling Translational Medicine with e-ScienceOla Spjuth
 
Palliative care: Pain Management for Patient with Diagnosis of Stomach Cancer...
Palliative care: Pain Management for Patient with Diagnosis of Stomach Cancer...Palliative care: Pain Management for Patient with Diagnosis of Stomach Cancer...
Palliative care: Pain Management for Patient with Diagnosis of Stomach Cancer...Murray Tracey
 
Patient adherence – what’s the problem?
Patient adherence – what’s the problem?Patient adherence – what’s the problem?
Patient adherence – what’s the problem?PM Society
 
#Reducing errors in prescription
#Reducing errors in prescription#Reducing errors in prescription
#Reducing errors in prescriptionJagannath Thakur
 
Endocannabinoids..
Endocannabinoids..Endocannabinoids..
Endocannabinoids..Samin Sameed
 
Medicines optimisation: sharing best practices
Medicines optimisation: sharing best practicesMedicines optimisation: sharing best practices
Medicines optimisation: sharing best practicesAALForum
 
Primary pulmonary hypertension
Primary pulmonary hypertensionPrimary pulmonary hypertension
Primary pulmonary hypertensiondrvasudev007
 
Sindrome de takotsubo
Sindrome de takotsuboSindrome de takotsubo
Sindrome de takotsuboprimeromiltar
 
Medical Marijuana
Medical MarijuanaMedical Marijuana
Medical Marijuanataha_801
 
Understanding Narcotic Medications for Service Members
Understanding Narcotic Medications for Service MembersUnderstanding Narcotic Medications for Service Members
Understanding Narcotic Medications for Service Membersmilfamln
 
Geriatric Population. Geriatric Clinician Practice. Your Medicare, Long-Term ...
Geriatric Population. Geriatric Clinician Practice. Your Medicare, Long-Term ...Geriatric Population. Geriatric Clinician Practice. Your Medicare, Long-Term ...
Geriatric Population. Geriatric Clinician Practice. Your Medicare, Long-Term ...Michelle Peck
 
Shared Decision Making - for pharmacists
Shared Decision Making - for pharmacistsShared Decision Making - for pharmacists
Shared Decision Making - for pharmacistsHugo Leung
 

Viewers also liked (20)

How to Reduce Readmissions by Changing Patient Education
How to Reduce Readmissions by Changing Patient EducationHow to Reduce Readmissions by Changing Patient Education
How to Reduce Readmissions by Changing Patient Education
 
8. Acute Lymphoblastic Leukemia
8. Acute Lymphoblastic Leukemia8. Acute Lymphoblastic Leukemia
8. Acute Lymphoblastic Leukemia
 
Medicines optimisation, pop up uni, 9am, 3 september 2015
Medicines optimisation, pop up uni, 9am, 3 september 2015Medicines optimisation, pop up uni, 9am, 3 september 2015
Medicines optimisation, pop up uni, 9am, 3 september 2015
 
Takotsubo
TakotsuboTakotsubo
Takotsubo
 
Providing quality pediatric pain management during end of life care
Providing quality pediatric pain management during end of life careProviding quality pediatric pain management during end of life care
Providing quality pediatric pain management during end of life care
 
Enabling Translational Medicine with e-Science
Enabling Translational Medicine with e-ScienceEnabling Translational Medicine with e-Science
Enabling Translational Medicine with e-Science
 
Palliative care: Pain Management for Patient with Diagnosis of Stomach Cancer...
Palliative care: Pain Management for Patient with Diagnosis of Stomach Cancer...Palliative care: Pain Management for Patient with Diagnosis of Stomach Cancer...
Palliative care: Pain Management for Patient with Diagnosis of Stomach Cancer...
 
Patient adherence – what’s the problem?
Patient adherence – what’s the problem?Patient adherence – what’s the problem?
Patient adherence – what’s the problem?
 
#Reducing errors in prescription
#Reducing errors in prescription#Reducing errors in prescription
#Reducing errors in prescription
 
Medicines Optimisation and NHS Right Care
Medicines Optimisation and NHS Right CareMedicines Optimisation and NHS Right Care
Medicines Optimisation and NHS Right Care
 
Non Medical Use of Prescription Drugs October 2016
Non Medical Use of Prescription Drugs October 2016Non Medical Use of Prescription Drugs October 2016
Non Medical Use of Prescription Drugs October 2016
 
Endocannabinoids..
Endocannabinoids..Endocannabinoids..
Endocannabinoids..
 
Medicines optimisation: sharing best practices
Medicines optimisation: sharing best practicesMedicines optimisation: sharing best practices
Medicines optimisation: sharing best practices
 
Primary pulmonary hypertension
Primary pulmonary hypertensionPrimary pulmonary hypertension
Primary pulmonary hypertension
 
Canabbis
CanabbisCanabbis
Canabbis
 
Sindrome de takotsubo
Sindrome de takotsuboSindrome de takotsubo
Sindrome de takotsubo
 
Medical Marijuana
Medical MarijuanaMedical Marijuana
Medical Marijuana
 
Understanding Narcotic Medications for Service Members
Understanding Narcotic Medications for Service MembersUnderstanding Narcotic Medications for Service Members
Understanding Narcotic Medications for Service Members
 
Geriatric Population. Geriatric Clinician Practice. Your Medicare, Long-Term ...
Geriatric Population. Geriatric Clinician Practice. Your Medicare, Long-Term ...Geriatric Population. Geriatric Clinician Practice. Your Medicare, Long-Term ...
Geriatric Population. Geriatric Clinician Practice. Your Medicare, Long-Term ...
 
Shared Decision Making - for pharmacists
Shared Decision Making - for pharmacistsShared Decision Making - for pharmacists
Shared Decision Making - for pharmacists
 

Similar to Quality Use of Medicines

Introduction to Quality use of medicine.pptx
Introduction to Quality use of medicine.pptxIntroduction to Quality use of medicine.pptx
Introduction to Quality use of medicine.pptxDnyaneshwariMate1
 
Essential drug concept & Rational drug use.pptx
Essential drug concept & Rational drug use.pptxEssential drug concept & Rational drug use.pptx
Essential drug concept & Rational drug use.pptxDr.Navaneethakrishnan S
 
Community pharmacy
Community pharmacyCommunity pharmacy
Community pharmacyharoon41us
 
Drug formulary.pptx.....................
Drug formulary.pptx.....................Drug formulary.pptx.....................
Drug formulary.pptx.....................loreensinkende
 
National drug policy.update
National drug policy.updateNational drug policy.update
National drug policy.updateSiham Abdallaha
 
Marketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_finalMarketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_finalJorgeventura2014
 
Marketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_finalMarketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_finalGeorgi Daskalov
 
Pharmacist care services.pptx
Pharmacist care services.pptxPharmacist care services.pptx
Pharmacist care services.pptxarslan8262
 
An introduction to medication therapy management
An introduction to medication therapy managementAn introduction to medication therapy management
An introduction to medication therapy managementKabito Kiwanuka
 
Introduction to Social Pharmacy.pptx
Introduction to Social Pharmacy.pptxIntroduction to Social Pharmacy.pptx
Introduction to Social Pharmacy.pptxishikachoudhary6
 
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...HFG Project
 
National Essential Drugs.pptx
National Essential Drugs.pptxNational Essential Drugs.pptx
National Essential Drugs.pptxRahat Aziz
 
Rational drug therapy A.R.S.
Rational drug therapy A.R.S.Rational drug therapy A.R.S.
Rational drug therapy A.R.S.Mdshams244
 
Governance, transparency and Accountability~ MeTA objectives, approaches and ...
Governance, transparency and Accountability~ MeTA objectives, approaches and ...Governance, transparency and Accountability~ MeTA objectives, approaches and ...
Governance, transparency and Accountability~ MeTA objectives, approaches and ...MeTApresents
 
Governance transparency and accountability
Governance transparency and accountabilityGovernance transparency and accountability
Governance transparency and accountabilityMeTApresents
 
“Unlocking Wellness: The Impact of Pharmacy Wellness Programs on Overall Health“
“Unlocking Wellness: The Impact of Pharmacy Wellness Programs on Overall Health““Unlocking Wellness: The Impact of Pharmacy Wellness Programs on Overall Health“
“Unlocking Wellness: The Impact of Pharmacy Wellness Programs on Overall Health“bluetroyvictorVinay
 

Similar to Quality Use of Medicines (20)

Introduction to Quality use of medicine.pptx
Introduction to Quality use of medicine.pptxIntroduction to Quality use of medicine.pptx
Introduction to Quality use of medicine.pptx
 
In patient care
In patient careIn patient care
In patient care
 
Hash 1-1.pptx
Hash 1-1.pptxHash 1-1.pptx
Hash 1-1.pptx
 
Essential drug concept & Rational drug use.pptx
Essential drug concept & Rational drug use.pptxEssential drug concept & Rational drug use.pptx
Essential drug concept & Rational drug use.pptx
 
Community pharmacy
Community pharmacyCommunity pharmacy
Community pharmacy
 
Drug formulary.pptx.....................
Drug formulary.pptx.....................Drug formulary.pptx.....................
Drug formulary.pptx.....................
 
National drug policy.update
National drug policy.updateNational drug policy.update
National drug policy.update
 
Marketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_finalMarketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_final
 
Marketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_finalMarketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_final
 
Concepts of em
Concepts of emConcepts of em
Concepts of em
 
Pharmacist care services.pptx
Pharmacist care services.pptxPharmacist care services.pptx
Pharmacist care services.pptx
 
An introduction to medication therapy management
An introduction to medication therapy managementAn introduction to medication therapy management
An introduction to medication therapy management
 
Introduction to Social Pharmacy.pptx
Introduction to Social Pharmacy.pptxIntroduction to Social Pharmacy.pptx
Introduction to Social Pharmacy.pptx
 
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...
 
National Essential Drugs.pptx
National Essential Drugs.pptxNational Essential Drugs.pptx
National Essential Drugs.pptx
 
Rational drug therapy A.R.S.
Rational drug therapy A.R.S.Rational drug therapy A.R.S.
Rational drug therapy A.R.S.
 
Patient centric strategy
Patient centric strategyPatient centric strategy
Patient centric strategy
 
Governance, transparency and Accountability~ MeTA objectives, approaches and ...
Governance, transparency and Accountability~ MeTA objectives, approaches and ...Governance, transparency and Accountability~ MeTA objectives, approaches and ...
Governance, transparency and Accountability~ MeTA objectives, approaches and ...
 
Governance transparency and accountability
Governance transparency and accountabilityGovernance transparency and accountability
Governance transparency and accountability
 
“Unlocking Wellness: The Impact of Pharmacy Wellness Programs on Overall Health“
“Unlocking Wellness: The Impact of Pharmacy Wellness Programs on Overall Health““Unlocking Wellness: The Impact of Pharmacy Wellness Programs on Overall Health“
“Unlocking Wellness: The Impact of Pharmacy Wellness Programs on Overall Health“
 

Recently uploaded

一比一原版(UPenn毕业证书)宾夕法尼亚大学毕业证成绩单学位证书
一比一原版(UPenn毕业证书)宾夕法尼亚大学毕业证成绩单学位证书一比一原版(UPenn毕业证书)宾夕法尼亚大学毕业证成绩单学位证书
一比一原版(UPenn毕业证书)宾夕法尼亚大学毕业证成绩单学位证书atedyxc
 
FEW OF THE DEVELOPMENTS FOUND IN LESOTHO
FEW OF THE DEVELOPMENTS FOUND IN LESOTHOFEW OF THE DEVELOPMENTS FOUND IN LESOTHO
FEW OF THE DEVELOPMENTS FOUND IN LESOTHOMantsepisengTubatsi
 
Module 1 CCP - Introduction and LMS.pptx
Module 1 CCP - Introduction and LMS.pptxModule 1 CCP - Introduction and LMS.pptx
Module 1 CCP - Introduction and LMS.pptxbaharudinbn
 
Shrambal_Distributors_Newsletter_May-2024.pdf
Shrambal_Distributors_Newsletter_May-2024.pdfShrambal_Distributors_Newsletter_May-2024.pdf
Shrambal_Distributors_Newsletter_May-2024.pdfvikashdidwania1
 
20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdf
20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdf20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdf
20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdfAdnet Communications
 
certified amil baba ,black magic specialist in russia and kala jadu expert in...
certified amil baba ,black magic specialist in russia and kala jadu expert in...certified amil baba ,black magic specialist in russia and kala jadu expert in...
certified amil baba ,black magic specialist in russia and kala jadu expert in...israjan914
 
GIFT City Overview India's Gateway to Global Finance
GIFT City Overview India's Gateway to Global FinanceGIFT City Overview India's Gateway to Global Finance
GIFT City Overview India's Gateway to Global FinanceGaurav Kanudawala
 
Pitch-deck CopyFinancial and MemberForex.ppsx
Pitch-deck CopyFinancial and MemberForex.ppsxPitch-deck CopyFinancial and MemberForex.ppsx
Pitch-deck CopyFinancial and MemberForex.ppsxFuadS2
 
Retail sector trends for 2024 | European Business Review
Retail sector trends for 2024 | European Business ReviewRetail sector trends for 2024 | European Business Review
Retail sector trends for 2024 | European Business ReviewAntonis Zairis
 
TriStar Gold- 05-13-2024 corporate presentation
TriStar Gold- 05-13-2024 corporate presentationTriStar Gold- 05-13-2024 corporate presentation
TriStar Gold- 05-13-2024 corporate presentationAdnet Communications
 
一比一原版(Caltech毕业证书)加利福尼亚理工学院毕业证成绩单学位证书
一比一原版(Caltech毕业证书)加利福尼亚理工学院毕业证成绩单学位证书一比一原版(Caltech毕业证书)加利福尼亚理工学院毕业证成绩单学位证书
一比一原版(Caltech毕业证书)加利福尼亚理工学院毕业证成绩单学位证书atedyxc
 
一比一原版(UC Davis毕业证书)加州大学戴维斯分校毕业证成绩单学位证书
一比一原版(UC Davis毕业证书)加州大学戴维斯分校毕业证成绩单学位证书一比一原版(UC Davis毕业证书)加州大学戴维斯分校毕业证成绩单学位证书
一比一原版(UC Davis毕业证书)加州大学戴维斯分校毕业证成绩单学位证书atedyxc
 
Rapport annuel de Encevo Group pour l'année 2023
Rapport annuel de Encevo Group pour l'année 2023Rapport annuel de Encevo Group pour l'année 2023
Rapport annuel de Encevo Group pour l'année 2023Paperjam_redaction
 
Amil baba australia kala jadu in uk black magic in usa
Amil baba australia kala jadu in uk black magic in usaAmil baba australia kala jadu in uk black magic in usa
Amil baba australia kala jadu in uk black magic in usaisrajan914
 
a study on customer perception towards mutual funds
a study on customer perception towards mutual fundsa study on customer perception towards mutual funds
a study on customer perception towards mutual fundsShivangiChaurasiya3
 
Satoshi DEX Leverages Layer 2 To Transform DeFi Ecosystem.pdf
Satoshi DEX Leverages Layer 2 To Transform DeFi Ecosystem.pdfSatoshi DEX Leverages Layer 2 To Transform DeFi Ecosystem.pdf
Satoshi DEX Leverages Layer 2 To Transform DeFi Ecosystem.pdfcoingabbar
 
ACC311_Corporate Income Taxation in the Philippines
ACC311_Corporate Income Taxation in the PhilippinesACC311_Corporate Income Taxation in the Philippines
ACC311_Corporate Income Taxation in the PhilippinesAdrinneFlores
 
amil baba in australia amil baba in canada amil baba in london amil baba in g...
amil baba in australia amil baba in canada amil baba in london amil baba in g...amil baba in australia amil baba in canada amil baba in london amil baba in g...
amil baba in australia amil baba in canada amil baba in london amil baba in g...israjan914
 

Recently uploaded (20)

一比一原版(UPenn毕业证书)宾夕法尼亚大学毕业证成绩单学位证书
一比一原版(UPenn毕业证书)宾夕法尼亚大学毕业证成绩单学位证书一比一原版(UPenn毕业证书)宾夕法尼亚大学毕业证成绩单学位证书
一比一原版(UPenn毕业证书)宾夕法尼亚大学毕业证成绩单学位证书
 
FEW OF THE DEVELOPMENTS FOUND IN LESOTHO
FEW OF THE DEVELOPMENTS FOUND IN LESOTHOFEW OF THE DEVELOPMENTS FOUND IN LESOTHO
FEW OF THE DEVELOPMENTS FOUND IN LESOTHO
 
Module 1 CCP - Introduction and LMS.pptx
Module 1 CCP - Introduction and LMS.pptxModule 1 CCP - Introduction and LMS.pptx
Module 1 CCP - Introduction and LMS.pptx
 
Shrambal_Distributors_Newsletter_May-2024.pdf
Shrambal_Distributors_Newsletter_May-2024.pdfShrambal_Distributors_Newsletter_May-2024.pdf
Shrambal_Distributors_Newsletter_May-2024.pdf
 
20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdf
20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdf20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdf
20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdf
 
certified amil baba ,black magic specialist in russia and kala jadu expert in...
certified amil baba ,black magic specialist in russia and kala jadu expert in...certified amil baba ,black magic specialist in russia and kala jadu expert in...
certified amil baba ,black magic specialist in russia and kala jadu expert in...
 
GIFT City Overview India's Gateway to Global Finance
GIFT City Overview India's Gateway to Global FinanceGIFT City Overview India's Gateway to Global Finance
GIFT City Overview India's Gateway to Global Finance
 
Pitch-deck CopyFinancial and MemberForex.ppsx
Pitch-deck CopyFinancial and MemberForex.ppsxPitch-deck CopyFinancial and MemberForex.ppsx
Pitch-deck CopyFinancial and MemberForex.ppsx
 
Retail sector trends for 2024 | European Business Review
Retail sector trends for 2024 | European Business ReviewRetail sector trends for 2024 | European Business Review
Retail sector trends for 2024 | European Business Review
 
TriStar Gold- 05-13-2024 corporate presentation
TriStar Gold- 05-13-2024 corporate presentationTriStar Gold- 05-13-2024 corporate presentation
TriStar Gold- 05-13-2024 corporate presentation
 
一比一原版(Caltech毕业证书)加利福尼亚理工学院毕业证成绩单学位证书
一比一原版(Caltech毕业证书)加利福尼亚理工学院毕业证成绩单学位证书一比一原版(Caltech毕业证书)加利福尼亚理工学院毕业证成绩单学位证书
一比一原版(Caltech毕业证书)加利福尼亚理工学院毕业证成绩单学位证书
 
一比一原版(UC Davis毕业证书)加州大学戴维斯分校毕业证成绩单学位证书
一比一原版(UC Davis毕业证书)加州大学戴维斯分校毕业证成绩单学位证书一比一原版(UC Davis毕业证书)加州大学戴维斯分校毕业证成绩单学位证书
一比一原版(UC Davis毕业证书)加州大学戴维斯分校毕业证成绩单学位证书
 
DIGITAL COMMERCE SHAPE VIETNAMESE SHOPPING HABIT IN 4.0 INDUSTRY
DIGITAL COMMERCE SHAPE VIETNAMESE SHOPPING HABIT IN 4.0 INDUSTRYDIGITAL COMMERCE SHAPE VIETNAMESE SHOPPING HABIT IN 4.0 INDUSTRY
DIGITAL COMMERCE SHAPE VIETNAMESE SHOPPING HABIT IN 4.0 INDUSTRY
 
Rapport annuel de Encevo Group pour l'année 2023
Rapport annuel de Encevo Group pour l'année 2023Rapport annuel de Encevo Group pour l'année 2023
Rapport annuel de Encevo Group pour l'année 2023
 
Looking for safe abortion pills? Dial +971581248768 for availability in Dubai...
Looking for safe abortion pills? Dial +971581248768 for availability in Dubai...Looking for safe abortion pills? Dial +971581248768 for availability in Dubai...
Looking for safe abortion pills? Dial +971581248768 for availability in Dubai...
 
Amil baba australia kala jadu in uk black magic in usa
Amil baba australia kala jadu in uk black magic in usaAmil baba australia kala jadu in uk black magic in usa
Amil baba australia kala jadu in uk black magic in usa
 
a study on customer perception towards mutual funds
a study on customer perception towards mutual fundsa study on customer perception towards mutual funds
a study on customer perception towards mutual funds
 
Satoshi DEX Leverages Layer 2 To Transform DeFi Ecosystem.pdf
Satoshi DEX Leverages Layer 2 To Transform DeFi Ecosystem.pdfSatoshi DEX Leverages Layer 2 To Transform DeFi Ecosystem.pdf
Satoshi DEX Leverages Layer 2 To Transform DeFi Ecosystem.pdf
 
ACC311_Corporate Income Taxation in the Philippines
ACC311_Corporate Income Taxation in the PhilippinesACC311_Corporate Income Taxation in the Philippines
ACC311_Corporate Income Taxation in the Philippines
 
amil baba in australia amil baba in canada amil baba in london amil baba in g...
amil baba in australia amil baba in canada amil baba in london amil baba in g...amil baba in australia amil baba in canada amil baba in london amil baba in g...
amil baba in australia amil baba in canada amil baba in london amil baba in g...
 

Quality Use of Medicines

  • 1. Quality Use of Medicines A brief summary
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9. Central Objectives ACCESS Timely access to medicines, at a cost the individual and community can afford QUALITY PRODUCTS Medicines meet Appropriate standards of quality, safety and efficacy QUALITY USE OF MEDICINES Judicious, appropriate, safe and effective use of medicines INDUSTRY Maintenance of a responsible and viable medicines industry
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.